Viking Therapeutics, INC. (VKTX) SEC Filings — 2024
24 SEC filings for Viking Therapeutics, INC. (VKTX) in 2024.
Filings
- Viking Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Viking Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Viking Therapeutics Files 8-K — 8-K · Nov 4, 2024
- Viking Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Viking Therapeutics Files Q3 2024 10-Q — 10-Q · Oct 23, 2024
- Viking Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 18, 2024
- Viking Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Aug 7, 2024
- Viking Therapeutics Files Q2 2024 10-Q — 10-Q · Jul 24, 2024
- Viking Therapeutics Files 8-K — 8-K · Jun 4, 2024
- Viking Therapeutics Announces Annual Meeting Results — 8-K · May 23, 2024
- Viking Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · Apr 25, 2024
- Viking Therapeutics Files 8-K on Operations — 8-K · Apr 24, 2024
- Viking Therapeutics Files DEF 14A with SEC — DEF 14A · Apr 5, 2024
- Viking Therapeutics Files 8-K — 8-K · Mar 26, 2024
- Viking Therapeutics Files 8-K — 8-K · Mar 4, 2024
- Viking Therapeutics Files 8-K Report — 8-K · Mar 1, 2024
- Viking Therapeutics Files Routine 8-K for Regulatory Disclosure — 8-K · Feb 27, 2024
- Viking Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Viking Therapeutics, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- FMR LLC & Abigail Johnson Report 14.999% Stake in Viking Therapeutics — SC 13G/A · Feb 9, 2024
- Viking Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 7, 2024
- BlackRock Discloses Passive Stake in Viking Therapeutics (VKNG) — SC 13G · Jan 26, 2024
- State Street Corp. Amends Viking Therapeutics Stake Disclosure — SC 13G/A · Jan 24, 2024
- Millennium Management Updates VKTX Stake as of Dec 31, 2023 — SC 13G/A · Jan 12, 2024